Troutman Pepper Locke attorneys Joseph Kadlec and Douglas Gray recently authored the Reuters Legal News article “Pipeline Gaps Create M&A Opportunities for Deal-Ready Life Sciences Companies,” where they discuss how late-stage biotech and biopharma companies can best position themselves for M&A opportunities in 2026.